Cell therapy for ischaemic heart disease: Focus on the role of resident cardiac stem cells

Netherlands Heart Journal

Volumn 17, Issue 5, 2009, Pages 199-207

  Chamuleau, S A J ^a,b,c,d   Vrijsen, K R ^a,c   Rokosh, D G ^a   Tang, X L ^a   Piek, J J ^b   Bolli, R ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiac stem cell; Ischaemic heart disease; Regeneration; Stem cell therapy

Indexed keywords

ATAXIN 1; ISLET 1 PROTEIN; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; STEM CELL FACTOR; UNCLASSIFIED DRUG;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIAC STEM CELL; CARDIOSPHERE; CELL POPULATION; CLINICAL TRIAL; EMBRYONIC STEM CELL; HEART FAILURE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MUSCLE REGENERATION; NONHUMAN; REVIEW; SCAR; SIDE POPULATION CELL; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 70349293932     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086247     Document Type: Review

References (72)

1. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115: 572-583 (Pubitemid 40322227)
2. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-776 (Pubitemid 37186770)
3. Fijnvandraat AC, Moorman AF. [Stem cells: biology and possible application to myocardial infarct]. Ned Tijdschr Geneeskd 2004; 148:1186-1191
4. Oettgen P. Cardiac stem cell therapy; Need for optimization of efficacy and safety monitoring. Circulation 2006;114:353-358 (Pubitemid 44297101)
5. de Muinck E, Thompson C, Simons M. Progress and prospects: Cell based regenerative therapy for cardiovascular disease. Gene Ther 2006;13:659-671
6. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414 (Pubitemid 32730787)
7. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007;50:1884-1893 (Pubitemid 350007960)
8. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 2002;91:866-876 (Pubitemid 35373586)
9. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147
10. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402 (Pubitemid 32522033)
11. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705 (Pubitemid 32290358)
12. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705. (Pubitemid 29122423)
13. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98 (Pubitemid 34049148)
14. Atsma DE, Fibbe WE, Rabelink TJ. Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol 2007;18:645-649 (Pubitemid 350098569)
15. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436 (Pubitemid 32298545)
16. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 2003;107:3093-3100 (Pubitemid 36758985)
17. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
18. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668 (Pubitemid 38524810)
19. Chien KR. Stem cells: lost in translation. Nature 2004;428:607-608
20. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918 (Pubitemid 35176294)
21. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-1232 (Pubitemid 44427446)
22. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209 (Pubitemid 44427444)
23. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221 (Pubitemid 44427445)
24. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997 (Pubitemid 46835786)
25. Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, et al. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Catheter Cardiovasc Interv 2008;71:273-281
26. Rosenzweig A. Cardiac Cell Therapy - Mixed Results from Mixed Cells. N Engl J Med 2006;355:1274-1277 (Pubitemid 44427452)
27. Arnesen H, Lunde K, Aakhus S, Forfang K. Cell therapy in myocardial infarction. Lancet 2007;369:2142-2143
28. Boyle AJ, Schulman SP, Hare JM. Stem cell therapy for cardiac repair. Circulation 2006;114:339-352
29. Fuster V, Sanz J, Viles-Gonzalez JF, Rajagopalan S. The utility of magnetic resonance imaging in cardiac tissue regeneration trials. Nat Clin Pract Cardiovasc Med 2006;(3 Suppl 1):S2-7. (Pubitemid 43315466)
30. Bartunek J, Wijns W, Heyndrickx GR, Vanderheyden M. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1):S52-6. (Pubitemid 43315476)
31. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: doubleblind, randomised controlled trial. Lancet 2006;367:113-121 (Pubitemid 43077127)
32. Ge J, Li Y, Qian J, Shi J, Wang Q, Niu Y, et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006;92:1764-1767 (Pubitemid 44851319)
33. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett 2002;530:239-243 (Pubitemid 35248218)
34. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-1757 (Pubitemid 32497029)
35. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, et al. Adult Cardiac Sca-1-positive Cells Differentiate into Beating Cardiomyocytes. J Biol Chem 2004;279:11384-11391 (Pubitemid 38401637)
36. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002;415:240-243
37. Goumans MJ, de Boer TP, Smits AM, Laake LW, van Vliet P, Metz CHG, et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2008;1:138-149 (Pubitemid 351734784)
38. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R, et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 2005;102:3766-3771 (Pubitemid 40354686)
39. Nadin BM, Goodell MA, Hirschi KK. Phenotype and hematopoietic potential of side population cells throughout embryonic development. Blood 2003;102:2436-2443
40. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95:911-921 (Pubitemid 39435006)
41. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003;100:12313-12318 (Pubitemid 37271557)
42. van Vliet P, Sluijter JP, Doevendans PA, Goumans MJ. Isolation and expansion of resident cardiac progenitor cells. Expert Rev Cardiovasc Ther 2007;5:33-43. (Pubitemid 46157739)
43. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004;265:262-275 (Pubitemid 38018836)
44. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A, et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005;97: 52-61. (Pubitemid 40982322)
45. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-653 (Pubitemid 40282999)
46. van Vliet P, Roccio M, Smits AM, van Oorschot AA, Metz CH, van Veen TA, et al. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J 2008;16:163-169
47. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007;104:14068-14073
48. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7: 1028-1034 (Pubitemid 32937383)
49. Bolli R, Jneid H, Tang XL, Dawn B, Rimoldi O, Mosna F, et al. Intracoronary administration of cardiac stem cells improves cardiac function in pigs with old infarction. Circulation 2006;114(suppl II):II-239 (abstract).
50. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006;24: 1779-1788 (Pubitemid 44474191)
51. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115:896-908. (Pubitemid 46294730)
52. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-1877 (Pubitemid 44033311)
53. Anversa P, Leri A, Kajstura J. Cardiac Regeneration. J Am Coll Cardiol 2006;47:1769-1776
54. Bolli R. Foreword - focused issue on cardiac repair by stem cells. Basic Res Cardiol 2005;100:469-470 (Pubitemid 41662426)
55. Chien KR. Lost and found: cardiac stem cell therapy revisited. J Clin Invest 2006;116:1838-1840 (Pubitemid 44033307)
56. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-669 (Pubitemid 44933310)
57. Timmers L, Kiang Lim S, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Research 2008;1:129-137 (Pubitemid 351736003)
58. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Amano K, Iba O, et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 2002;22:1804-1810 (Pubitemid 35315765)
59. Yoshioka T, Ageyama N, Shibata H, Yasu T, Misawa Y, Takeuchi K, et al. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 2005;23:355-364 (Pubitemid 40404454)
60. Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: Rationale and design of the HEBE trial - A prospective, multicenter, randomized trial. Am Heart J 2006;152:434-441 (Pubitemid 44233416)
61. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006;27:1114-1122
62. Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T. Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med 2006;(3 Suppl 1):S57-64.
63. Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, Kastrup J. Intramyocardial injection of vascular endothelial growth factor- A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J 2006;27:1785-1792 (Pubitemid 44297382)
64. Smits PC, van Langenhove G, Schaar M, Reijs A, Bakker WH, van der Giessen WJ, et al. Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based catheter system. Cardiovasc Drugs Ther 2002;16:527-533 (Pubitemid 36521002)
65. Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001;103:2138-2143
66. Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol 2007;100:1094-1098 (Pubitemid 47404464)
67. San Roman JA, Fernandez-Aviles F. The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1):S38-41. (Pubitemid 43315473)
68. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, et al. Overexpression of Insulin-like Growth Factor-1 in Mice Protects from Myocyte Death after Infarction, Attenuating Ventricular Dilation, Wall Stress, and Cardiac Hypertrophy. J Clin Invest 1997;100:1991-1999 (Pubitemid 27459352)
69. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005;97:663-673 (Pubitemid 41416335)
70. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 2005;102:8966-8971 (Pubitemid 40881062)
71. Davis ME, Hsieh PCH, Takahashi T, Song Q, Zhang S, Kamm RD, et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 2006;103: 8155-8160 (Pubitemid 43801068)
72. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9: 1195-1201 (Pubitemid 37173705)